Nanfang Hospital, Southern Medical University: clinical-trial pipeline
Nanfang Hospital, Southern Medical University is the sponsor of 488 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 167 are not yet finished and 10 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Open trials167
Phase 2/3 and 355
Countries7
New in 90 days10
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 324 |
| Phase 2 | 57 |
| Phase 4 | 39 |
| Phase 2/3 | 37 |
| Phase 3 | 18 |
| Phase 1/2 | 7 |
| Phase 1 | 4 |
| Early phase 1 | 2 |
Trials by status
| Status | Trials |
|---|---|
| Unknown | 241 |
| Recruiting | 101 |
| Completed | 75 |
| Not yet recruiting | 54 |
| Active, not recruiting | 12 |
| Withdrawn or not authorised | 3 |
| Terminated | 2 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 205 |
| Gastroenterology and liver | 95 |
| Cardiovascular | 58 |
| Immunology and rheumatology | 58 |
| Infectious disease and vaccines | 51 |
| Metabolic and endocrine (diabetes, obesity) | 24 |
| Neurology | 24 |
| Haematology | 22 |
| Rare and genetic diseases | 15 |
| Nephrology and urology | 13 |
| Respiratory | 13 |
| Women's health and obstetrics | 10 |
Countries
| Country | Trials |
|---|---|
| China | 433 |
| Thailand | 2 |
| United Kingdom | 1 |
| Hong Kong SAR China | 1 |
| Indonesia | 1 |
| Italy | 1 |
| Japan | 1 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-21 | New trial posted | Jaktinib for Steroid-Refractory Acute Graft-Versus-Host Disease |
| 2026-10-05 | New trial posted | A Study on Associations Between Multidimensional Human Phenotypic Traits and Human Growth… |
| 2026-10-05 | New trial posted | Study on the Effect of Electronic Moxibustion on Non-Specific Low Back Pain in Young Adul… |
| 2026-09-24 | New trial posted | De-escalation Strategy of Tyrosine Kinase Inhibitors Before Treatment Discontinuation in… |
| 2026-09-24 | New trial posted | A Study on the Evaluation of College Students' Athletic Fitness Using a Data Model Integr… |
| 2026-09-15 | New trial posted | Dynamic Risk Prediction of Severe Myelosuppression in Nasopharyngeal Carcinoma |
| 2026-09-14 | New trial posted | Efficacy Evaluation of Turmeric-Derived Nanoparticle Hydrogel for the Treatment of Diabet… |
| 2026-09-10 | New trial posted | Plantar Stimulation, Whole-Body Vibration, and Baduanjin for Muscle Activation |
| 2026-09-09 | New trial posted | Effect of a Standardized Oral Care Program on Oral Mucositis in Children Undergoing Hemat… |
| 2026-09-02 | New trial posted | Self-Management Support for Acute Coronary Syndrome Patients After Hospital Discharge |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT07744087 | Modified Single-Incision Plus One-Port Versus Conventional Five-Port Laparoscopic Pancreaticoduodenectomy for… | Not applicable | Recruiting | China |
| NCT05129904 | Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard… | Not applicable | Active, not recruiting | China |
| NCT07700498 | PEI-GT Trial for Initial Treatment of Primary Open-Angle Glaucoma With Cataract | Not applicable | Recruiting | China |
| NCT03692143 | Comparation of Treatment Strategies for OVF: Teriparatide Injection and PVP | Not applicable | Active, not recruiting | |
| NCT07604298 | Efficacy and Safety of Indobufen, Aspirin, Cilostazol and Clopidogrel in the Treatment of Ischemic Stroke | Not applicable | Not yet recruiting | China |
| NCT07157618 | Prospective Pathology Foundation Models | Not applicable | Recruiting | China |
| NCT07839975 | A Study on the Evaluation of College Students' Athletic Fitness Using a Data Model Integrating Traditional Ch… | Not applicable | Recruiting | China |
| NCT05879783 | Optical Biopsy for Peritoneal Nodules in Colorectal Patients | Not applicable | Recruiting | China |
| NCT06952387 | PeRsonalized Blood prEssure Management on Postoperative Complications and Mortality in hIgh-risk Patients Und… | Not applicable | Recruiting | China |
| NCT05545605 | Efficacy and Safety of Sodium Oligomannate in the Prevention of PSCI | Not applicable | Recruiting | China |
| NCT06039696 | Pathogenic Metagenomic Next-generation Sequencing to Optimize the Diagnosis of Decompensated Cirrhosis Infect… | Not applicable | Recruiting | China |
| NCT06308328 | A Real-world Observational Study of a Mucosal Contouring Method for Radiation-induced Oropharyngeal Mucositis | Not applicable | Recruiting | China |
| NCT07071688 | Study of Peripheral Blood CHI3L1 to Predict Tumor Response to Radiotherapy | Not applicable | Not yet recruiting | China |
| NCT07857798 | A Study on Associations Between Multidimensional Human Phenotypic Traits and Human Growth and Development | Not applicable | Recruiting | China |
| NCT05875649 | A Multicenter Prospective Cohort Study Study of CLAG Regimen in Acute Myeloid Leukemia Patients With First-in… | Not applicable | Not yet recruiting | China |
| NCT07622693 | Beta-Blockers on Neoadjuvant Immunochemotherapy for Hypertensive Patients With Gastric Cancer | Not applicable | Active, not recruiting | China |
| NCT07003334 | Correlation of Psychological Distress and Immune Checkpoint Inhibitors in Gastric Cancer | Not applicable | Recruiting | China |
| NCT07775820 | PD-L1 Inhibitor Rechallenge After Immunotherapy-Related Pneumonitis in Patients With Lung Cancer | Not applicable | Recruiting | China |
| NCT05392413 | Immune Indicator Model for Predicting Efficacy of PD-1 Monoclonal Antibody | Not applicable | Recruiting | China |
| NCT06823895 | Pharmacokinetic Study of Oligonucleotides in Maixuekang Capsules | Phase 1 | Recruiting | China |
| NCT06584565 | A Multicenter Study Based on Multi-omics Analysis to Predict the Early Prognosis and Recurrence Risk of Acute… | Not applicable | Recruiting | China |
| NCT06310473 | Neoadjuvant Cadonilimab Plus Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Tr… | Phase 2 | Not yet recruiting | China |
| NCT06157996 | Lenvatinib Plus Tislelizumab and CapeOX as First-Line Treatment for Advanced GC/GEJC With Positive PD-L1 and… | Phase 2 | Recruiting | China |
| NCT07052422 | VEN+DAC+Bu2Flu4 vs Bu2Flu5 Conditioning Regimen for Elderly Myeloid Malignancies Undergoing Allo-HSCT | Phase 2/3 | Not yet recruiting | |
| NCT06017895 | Doxepin Solution for Alleviation of Stubborn Breakthrough Pain Induced by Swallowing in Patients Receiving Ra… | Not applicable | Recruiting | China |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Nanfang Hospital, Southern Medical University clinical trials: 167 open, 55 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/nanfang-hospital-southern-medical-university/, data as of 2026-10-25.